In order to realize the modernization and big span development, the company invested a huge amount of money to build a brand-new GMP new factory and passed the national certification. The new plant covers an area of more than 180 acres, building area of nearly 100,000 square meters;, equipped with the most advanced modern pharmaceutical equipment, formed an annual output value of more than 2 billion production capacity. From the factory appearance, hardware facilities, production capacity on the comprehensive consideration of the pharmaceutical industry in the province, Deyang is the only one. The main workshop is: construction area of 35,000 square meters. Equipped with the most advanced 10 tons of extraction tanks, 10 tons of concentration tanks, 6 cubic percolation tanks, 20 tons of three eccentric mixer, 300-type dryer (5), 24 hollow capsule production line, eccentric mixer, dryer, large storage tanks, capsule production line and other types of equipment, such as more than 500 units. Among them, 20 cubic meters eccentric tri-center mixing and 500-type dryer are the first in China and the first in Asia. It can produce 1.8 billion bags of granules, 500 million tinctures and 15 billion capsules annually.
For casting Shuzhong brand, to create "China's king of general medicine", in January 2008, the company in Guanghan City Economic Development Zone, the new industrial land of more than 300 acres, the implementation of modernization of the production line of traditional Chinese medicine phase III technical reform project, which is the company to achieve the leapfrog development of the company to take another major initiative. This project is the key technology transformation project in Sichuan Province in 2008, the company invested a total of 200,000,000 yuan in this project, with fixed assets of 180,000,000 yuan (including 300 acres of newly acquired land), and it is proposed to build an additional area of 100,000 square meters of production plants, warehouses, office facilities, scientific research and technology centers, and ancillary housing and so on. At present, the company's technological transformation project warehouse, production plant, office facilities and other civil engineering has been fully launched, is expected to be completed by the end of 2009, the second half of 2010 into full production. This technical reform project is designed and implemented with reasonable overall structure, equipped with more than 700 sets of various types of advanced production and testing equipment and supporting advanced sewage treatment system and fire safety system. This project has a leading edge in the field of Chinese medicine manufacturing in China. According to statistics, the company's three-phase technological transformation project will be put into full production after its production capacity will be doubled, while the new sales revenue of up to 600 million yuan, an additional profit of 50 million yuan, an additional 30 million yuan of taxes, 30 million yuan of foreign exchange per annum, to achieve the development of the enterprise by leaps and bounds.
September 2008, the company's scientific research building with strong strength, perfect, excellent quality assurance system, advanced scientific research and testing equipment, as well as first-class, professional scientific research team was recognized by the provincial "Shuzhong Pharmaceuticals Technology Center" honorary certificate, "Shuzhong Pharmaceuticals Technology Center" is the 10th Sichuan Province. The "Shuzhong Pharmaceutical Technology Center" is the thirteenth batch of enterprise technology centers recognized by Sichuan Province. This technology center is mainly used for new drug development, in-depth development of fist varieties, capacity transformation and energy saving and consumption reduction and other technological innovation activities, with 4000 square meters of experimental space, 181 technicians, 54 full-time researchers. Among them, there are 8 experts, 8 senior title personnel, 3 doctoral degree experts, 1 foreign experts involved in pharmacy, pharmacology, analytical chemistry, clinical pharmacology, organic synthesis and other specialties.A7003 atomic absorption spectrophotometer, TU-1201 UV-visible spectrophotometer and other development and testing equipment original value of 35 million yuan.07, 08 years the company invested R & D funds of 16 million yuan and 30 million yuan, respectively. In 2007 and 2008, the company invested 16 million yuan and 30 million yuan in R&D respectively. At present, it has completed 90 large projects, 43 new product research and development, and undertaken 6 national standards. The company's technology center will take independent innovation, project introduction, cooperative research and development means to build the center into the province's advanced preclinical drug testing center, and strive to 5 years of new sales revenue of 1 billion yuan, to achieve a profit of 200 million yuan. 5 years through the GLP certification, and initially achieve profitability.